Терапія остеопорозу у пацієнток із цукровим діабетом 2 типу в постменопаузі
DOI:
https://doi.org/10.24026/1818-1384.4(52).2015.76132Ключові слова:
цукровий діабет 2 типу, менопауза, остеопорозАнотація
У лекції представлені сучасні дані щодо патогенетично обґрунтованого вибору терапії остеопорозу у жінок постменопаузального віку, які хворіють на цукровий діабет 2 типу.
Посилання
Zhao L.J. et al. Relationship of obesity with osteoporosis // Clin. Endocrinol. Metab. – 2007. − No 92. – P. 1640–1646.https://doi.org/10.1210/jc.2006-0572
Weisberg S.P. et al. Obesity is associated with macrophage accumulation in adipose tissue // J. Clin. Invest. – 2003. – No 112. – P. 1796–1808.https://doi.org/10.1172/jci19246
Premaor M.O. et al. Obesity and fractures in postmenopausal women // J. Bone and Mineral. Research. – 2010. – No 25. – P. 292–297.https://doi.org/10.1359/jbmr.091004
Chiu K.C. et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction // Am. J. Clin. Nutr. – 2004. – No 79. – P. 820–825.
Muscogiuri G. et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity // Obesity (Silver Spring). – 2010. − No 18. – P. 1906–1910.https://doi.org/10.1038/oby.2010.11
Cutrim D.M. et al. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus // Braz. J. Med. Biol. Res. – 2007. − No 40. – P. 221–227.https://doi.org/10.1590/s0100-879x2006005000054
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta – analysis // Osteoporos. – 2007. – No 18. – P. 427–444. https://doi.org/10.1007/s00198-006-0253-4
Рожинская Л.Я. Системный остеопороз: практ. Руководство.
Kwon D.J. et al. Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus // J. Obstet. Gynaecol. Res. – 1996. − No 22. – P. 157–162.https://doi.org/10.1111/j.1447-0756.1996.tb00959.x
Husemoen L.L. et al. Serum 25(OH)D and Type 2 Diabetes Association in a General Population: а prospective study // Diabetes Care. – 2012. – No 35. – P. 1695–1700.https://doi.org/10.2337/dc11-1309
Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. – М.: ГЭОТАР-Медиа, 2011. – C. 704.
Мкртумян А.М. Оценка состояния костной ткани у больных сахарным диабетом // Остеопороз и остеопатии. – 2000. – No 1. – C. 27–30.
Isidro M.L., Ruano B. Bone disease in diabetes: Rev.; Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues // Curr. Diabetes Rev. – 2010. − No 6. – P. 144–155. https://doi.org/10.2174/157339910791162970
Shehab D. et al. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? // Diabet. Med. – 2012. – No 29. – P. 43–49.https://doi.org/10.1111/j.1464-5491.2011.03510.x
Soderstrom L.H. et al. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES // Diabet. Med. – 2012. – No 29. – P. 50–55.https://doi.org/10.1111/j.1464-5491.2011.03379.x
Schwartz A.V. et al. Older women with diabetes have an increased risk of fracture: a prospective study // J. Clin. Endocrinol. Metab. – 2001. − No 86. – P. 32–38.https://doi.org/10.1210/jcem.86.1.7139
Nicodemus K.K., Folsom A.R. Iowa Women’s Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women // Diabetes Care. – 2001. − No 24. – Р. 1192–1197. https://doi.org/10.2337/diacare.24.7.1192
Majima T. et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients // Osteoporos. Int. – 2005. – No 16. – P. 907–913.https://doi.org/10.1007/s00198-004-1786-z
Fukunaga Y., Does insulin use increase bone mineral density in patients with non-insulin-dependent diabetes mellitus? // Arch. Intern. Med. – 2005. – No 157. – P. 2668–2669. https://doi.org/10.1001/archinte.1997.00440430150029
Dennison E.M. et al. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? // Diabetologia. – 2004. – No 47. – P. 1963–1968.https://doi.org/10.1007/s00125-004-1560-y
Garg R. et al. Hip geometry in diabetic women: Implications for fracture risk // Metabolism. – 2012. – No 61. – P. 1756–1762.https://doi.org/10.1016/j.metabol.2012.05.010
Brown S.A., Sharpless J.L. Osteoporosis: an under-appreciated complication of diabetes // Clin. Diabetes. – 2004. – Vol. 2. – P. 10–20.https://doi.org/10.2337/diaclin.22.1.10
Saito J., Nishikawa T. Osteoporosis treatment in patients with hyperthyroidism // Nihon Rinsho. – 2009. – No 67. – P. 1011–1016.
Meunier P.J. et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis // N. Engl. J. Med. – 2004. – No 350. – P. 459–468.https://doi.org/10.1056/nejmoa022436
Ammann P. et al. Strontium ranelate improves bone resistance by increas-ing bone mass and improving architecture in intact female rats // J. Bone Miner. Res. – 2004. – No 19. – P. 2012–2020.https://doi.org/10.1359/jbmr.040906
Лесняк О.М. Аудит состояния проблемы остеопороза в Российской Федерации // Профилактическая медицина. – 2011. – No 2. – C. 7–10.
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2015 Клінічна ендокринологія та ендокринна хірургія
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
